SLC6A3 and depressive symptom measurement: They considered striatal dopaminergic D2/D3 receptor availability, explaining elevated dopaminergic neurotransmission in mania, and an increase in striatal dopamine transporter (DAT), elucidating lowered dopaminergic function in depression.